Aligos Therapeutics's grant share as of February 2024 was 8%. Grant share is based on the ratio of number of grants to total number of patents. A recently granted patent (Publication Number: ...
Ms. Bhattacharya will cover the development and application of Nanoscope's Multi-Characteristic Opsin (MCO) platform towards mutation-agnostic, restorative treatment of multiple orphan diseases ...
BATCH Full-Spectrum CBD Gummies full-spectrum 25 mg — Subscribe and save. PlusCBD CBD Gummies, Extra Strength Formula full-spectrum 10 mg 2 g Use code “healthline40” for 40% off. FOCL Full ...
Anish Patel, the Chief Operating Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), recently sold a total of $90,686 worth of company stock, according to the latest SEC filings. The transactions, ...
SAN DIEGO, April 8, 2024 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results